971 filings
Page 9 of 49
EFFECT
SRNEQ
Sorrento Therapeutics, Inc.
16 Jul 21
Notice of effectiveness
12:15am
424B3
SRNEQ
Sorrento Therapeutics, Inc.
15 Jul 21
Prospectus supplement
5:01pm
CORRESP
SRNEQ
Sorrento Therapeutics, Inc.
13 Jul 21
Correspondence with SEC
12:00am
UPLOAD
SRNEQ
Sorrento Therapeutics, Inc.
13 Jul 21
Letter from SEC
12:00am
8-K
SRNEQ
Sorrento Therapeutics, Inc.
8 Jul 21
Entry into a Material Definitive Agreement
4:01pm
8-K/A
SRNEQ
Sorrento Therapeutics, Inc.
2 Jul 21
Financial Statements and Exhibits
4:00pm
S-3
SRNEQ
Sorrento Therapeutics, Inc.
Shelf registration
25 Jun 21
4:14pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
4 Jun 21
Sorrento completes acquisition of acea therapeutics, creating a major oncology franchise
4:04pm
8-K
SRNEQ
Sorrento Therapeutics, Inc.
2 Jun 21
Other Events
7:00am
EFFECT
SRNEQ
Sorrento Therapeutics, Inc.
2 Jun 21
Notice of effectiveness
12:15am
424B3
SRNEQ
Sorrento Therapeutics, Inc.
1 Jun 21
Prospectus supplement
4:59pm
CORRESP
SRNEQ
Sorrento Therapeutics, Inc.
27 May 21
Correspondence with SEC
12:00am
UPLOAD
SRNEQ
Sorrento Therapeutics, Inc.
25 May 21
Letter from SEC
12:00am
S-3
SRNEQ
Sorrento Therapeutics, Inc.
Shelf registration
19 May 21
5:29pm
10-Q
2021 Q1
SRNEQ
Sorrento Therapeutics, Inc.
Quarterly report
5 May 21
4:35pm
EFFECT
SRNEQ
Sorrento Therapeutics, Inc.
20 Apr 21
Notice of effectiveness
12:15am
424B3
SRNEQ
Sorrento Therapeutics, Inc.
20 Apr 21
Prospectus supplement
12:00am
4
Janda Kim
15 Apr 21
Sorrento Therapeutics / Kim Janda ownership change
6:43pm
UPLOAD
SRNEQ
Sorrento Therapeutics, Inc.
14 Apr 21
Letter from SEC
12:00am
CORRESP
SRNEQ
Sorrento Therapeutics, Inc.
14 Apr 21
Correspondence with SEC
12:00am